Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058226 · ClinicalTrials.gov registry record · Phase 1
Reproducibility of Malaria Challenge in Healthy Volunteers
A Phase 1 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01058226 is a Phase 1 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 6 participants.
The verdict
NCT01058226, a Phase 1 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the well-established malaria challenge model at the Seattle Biomedical Research Institute (Seattle BioMed).
Interventions
- BIOLOGICAL Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01058226
The ClinicalTrials.gov registry entry for NCT01058226 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites) is the first listed.
NCT01058226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01058226 about?
NCT01058226 is a clinical study titled "Reproducibility of Malaria Challenge in Healthy Volunteers". This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the well-established malaria challenge model at the Seattle Biomedical Research Institute (Seattle BioMed).
What is the current status of trial NCT01058226?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2010-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01058226?
The interventions under investigation include: Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01058226?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.